PolitiKit

DENTAL CARE FUNDING: discussions around the federal budgetary process and program development with regard to funding of dental care, including the Canadian Dental Care Plan.

DENTAL EDUCATION: Increase funding for Canadian Faculties of Dentistry.

INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care.

PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories.

Discussion on the use of AI/digital health and how that can help improve the profession and more efficient access to care for patients.

Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.

Free trade agreements as they relate to the biopharmaceutical industry.

Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.

Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry.

Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.

Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products

Free trade agreements as they relate to the biopharmaceutical industry

Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework

Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations

Proposed pharmacare legislation related to any future national pharmacare program

Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes

Lobby for tax deductions that will encourage more Canadians to visit fitness facilities to improve their health and sustain employment within the fitness industry.

Amendments to the Food and Drugs Act – Ensure sensible rules for natural health products. Address prohibition on sampling of natural health products directly to the consumer. Implication of Health Canada’s proposed Consumer Health Products Framework. Consideration of the 53 recommendations made in 1998 by the Standing Committee on Health.

Government of Canada program and policy support for the natural health product, food, health product and overall commodity manufacturing sector's.

Scientific and analytical integrity in Health Canada's regulatory proposal Canada Gazette I & II, Volume 155, Number 26 and all other recent labeling laws including but not limited to Canada Gazette, Part II, Volume 156, Number 15.

Providing expert knowledge on paediatric health human resources, including supports for a healthier workforce that can meet the changing needs of children and youth.